| abstract |
The present invention provides antisense compounds targeting connexins and methods of use thereof. The present invention provides methods and compositions for modulating connexin activity, including, for example, for post-operative, traumatic, or tissue engineering applications. These compounds and methods can be used therapeutically, for example, to reduce the severity of adverse effects associated with diseases and disorders in which local disruption of direct intercellular communication is desired. |